Roger Diaz
Psychiatric/Mental Health · El Paso, TXNPI 1811485154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 243 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 32.5% of the total. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$568
- AbbVie$566
- Neurocrine Biosciences, Inc.$435
- Teva Pharmaceuticals USA, Inc.$324
- Axsome Therapeutics, Inc.$271
- plus $1K from 8 others
What the payments were for
- Food & beverage$4,68098%
- Education$712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 73 | $1,546 |
| Alkermes, Inc. | 17 | $568 |
| AbbVie | 43 | $566 |
| Neurocrine Biosciences, Inc. | 27 | $435 |
| Teva Pharmaceuticals USA, Inc. | 11 | $324 |
| Axsome Therapeutics, Inc. | 17 | $271 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $255 |
| Johnson & Johnson | 12 | $245 |
| Vanda Pharmaceuticals Inc. | 6 | $129 |
| Corium, LLC | 3 | $119 |
| Sunovion Pharmaceuticals Inc. | 7 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Lundbeck LLC | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$423
- ARISTADA INITIO$106
How this compares
$4,752 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 13 | $284 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in El Paso
- Victor IlogEl Paso$167K
- Alfredo ArellanoEl Paso$55K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.